Do GLP-1 doses 'wear off' before your next shot is due?

What did @gottafigurelikeagrandpa actually say?

Honestly, the transcript here is a wash. The creator's caption does the heavy lifting: they say "the dose wore off" over the weekend, gained two pounds, took their next shot Sunday, and declared they're "back." The actual spoken content is filler with no medical claims attached. So this fact-check is working from the caption, not a monologue packed with clinical assertions.

That framing still carries real assumptions worth examining. The creator implies GLP-1 medications work on a weekly on/off cycle, that weight fluctuations between doses reflect true fat gain, and that taking the next scheduled injection resets things. Those assumptions are common in GLP-1 communities online, and some of them hold up better than others.

Does the science back this up?

Partially. GLP-1 receptor agonists like semaglutide do have a half-life that influences appetite suppression across the week, but the picture is more complicated than a simple "on/off" switch.

Semaglutide (the active ingredient in Ozempic and Wegovy) has a half-life of approximately seven days, which is why weekly dosing works at all. But plasma concentration doesn't cliff-dive to zero on day seven. It tapers. A study by Lau et al. (2021, Diabetes, Obesity and Metabolism) found that steady-state plasma levels with once-weekly semaglutide take four to five weeks to stabilize, meaning early in treatment the end-of-week dip is more pronounced than it becomes later on.

As for the two-pound weekend gain: that almost certainly isn't two pounds of fat. To gain two pounds of actual adipose tissue, you'd need a roughly 7,000-calorie surplus over your baseline. What's more likely is fluid retention, glycogen replenishment from weekend eating patterns, or normal daily weight variance. Research consistently shows body weight can fluctuate one to three pounds in a single day based on sodium intake, hydration, and digestive contents (Orsama et al., 2014, Journal of Medical Internet Research).

What did they get wrong (or right)?

The creator got the general arc right: appetite suppression from semaglutide and tirzepatide isn't static across the week, and some people do report stronger hunger toward the end of their dosing window. That's a real, documented phenomenon, not imagined. A 2022 analysis from the STEP trial program noted that patient-reported appetite scores worsened slightly in the days before the next injection, particularly early in treatment.

Where the framing gets slippery is the "dose wore off" language. It implies a binary state, like a battery dying, when GLP-1 pharmacology doesn't really work that way. The medication is continuously present; it's the concentration that dips. Framing end-of-week hunger as total medication failure could lead people to conclude their dose is inadequate and push for escalation when what they're experiencing is normal pharmacokinetics.

The two-pound weight gain being attributed entirely to medication timing is also an oversimplification. Weekend eating patterns, alcohol, sodium, and reduced activity all contribute independently. Pinning it solely on "the dose wore off" removes personal agency from the equation in a way that isn't entirely accurate.

What should you actually know?

If you're on a weekly GLP-1 medication and noticing increased hunger before your next shot, you're not alone and you're not imagining it. But there are a few things worth keeping in mind before drawing conclusions.

• Normal weight fluctuation of one to three pounds across a week is expected for most adults, regardless of medication status. Daily weigh-ins are poor signals for actual fat loss or gain.
• The "end of week hunger" effect tends to diminish as you reach steady-state plasma concentrations, typically after the first month or two on a stable dose.
• If appetite suppression feels significantly inconsistent, that's a conversation to have with your prescriber, not a reason to self-adjust timing or dose. Injection day can sometimes be shifted under medical guidance to better fit your schedule.
• Two pounds over a weekend almost certainly reflects fluid and food volume, not fat. Attributing it to medication timing alone misses other contributing factors.

GLP-1 medications are genuinely effective tools for weight management when used as prescribed, but they work best alongside honest tracking of eating patterns, not just injection schedules.